Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Novel Benzene-Based Carbamates for AChE/BChE Inhibition: Synthesis and Ligand/Structure-Oriented SAR Study

A. Bak, V. Kozik, D. Kozakiewicz, K. Gajcy, DJ. Strub, A. Swietlicka, S. Stepankova, A. Imramovsky, J. Polanski, A. Smolinski, J. Jampilek,

. 2019 ; 20 (7) : . [pub] 20190327

Language English Country Switzerland

Document type Journal Article

Grant support
LO1305 Ministry of Education of the Czech Republic
APVV-17-0373 and APVV-14-0547 Slovak Research and Development Agency

A series of new benzene-based derivatives was designed, synthesized and comprehensively characterized. All of the tested compounds were evaluated for their in vitro ability to potentially inhibit the acetyl- and butyrylcholinesterase enzymes. The selectivity index of individual molecules to cholinesterases was also determined. Generally, the inhibitory potency was stronger against butyryl- compared to acetylcholinesterase; however, some of the compounds showed a promising inhibition of both enzymes. In fact, two compounds (23, benzyl ethyl(1-oxo-1-phenylpropan-2-yl)carbamate and 28, benzyl (1-(3-chlorophenyl)-1-oxopropan-2-yl) (methyl)carbamate) had a very high selectivity index, while the second one (28) reached the lowest inhibitory concentration IC50 value, which corresponds quite well with galanthamine. Moreover, comparative receptor-independent and receptor-dependent structure⁻activity studies were conducted to explain the observed variations in inhibiting the potential of the investigated carbamate series. The principal objective of the ligand-based study was to comparatively analyze the molecular surface to gain insight into the electronic and/or steric factors that govern the ability to inhibit enzyme activities. The spatial distribution of potentially important steric and electrostatic factors was determined using the probability-guided pharmacophore mapping procedure, which is based on the iterative variable elimination method. Additionally, planar and spatial maps of the host⁻target interactions were created for all of the active compounds and compared with the drug molecules using the docking methodology.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc19034673
003      
CZ-PrNML
005      
20191008105126.0
007      
ta
008      
191007s2019 sz f 000 0|eng||
009      
AR
024    7_
$a 10.3390/ijms20071524 $2 doi
035    __
$a (PubMed)30934674
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Bak, Andrzej $u Institute of Chemistry, University of Silesia, Szkolna 9, 40 007 Katowice, Poland. andrzej.bak@us.edu.pl.
245    10
$a Novel Benzene-Based Carbamates for AChE/BChE Inhibition: Synthesis and Ligand/Structure-Oriented SAR Study / $c A. Bak, V. Kozik, D. Kozakiewicz, K. Gajcy, DJ. Strub, A. Swietlicka, S. Stepankova, A. Imramovsky, J. Polanski, A. Smolinski, J. Jampilek,
520    9_
$a A series of new benzene-based derivatives was designed, synthesized and comprehensively characterized. All of the tested compounds were evaluated for their in vitro ability to potentially inhibit the acetyl- and butyrylcholinesterase enzymes. The selectivity index of individual molecules to cholinesterases was also determined. Generally, the inhibitory potency was stronger against butyryl- compared to acetylcholinesterase; however, some of the compounds showed a promising inhibition of both enzymes. In fact, two compounds (23, benzyl ethyl(1-oxo-1-phenylpropan-2-yl)carbamate and 28, benzyl (1-(3-chlorophenyl)-1-oxopropan-2-yl) (methyl)carbamate) had a very high selectivity index, while the second one (28) reached the lowest inhibitory concentration IC50 value, which corresponds quite well with galanthamine. Moreover, comparative receptor-independent and receptor-dependent structure⁻activity studies were conducted to explain the observed variations in inhibiting the potential of the investigated carbamate series. The principal objective of the ligand-based study was to comparatively analyze the molecular surface to gain insight into the electronic and/or steric factors that govern the ability to inhibit enzyme activities. The spatial distribution of potentially important steric and electrostatic factors was determined using the probability-guided pharmacophore mapping procedure, which is based on the iterative variable elimination method. Additionally, planar and spatial maps of the host⁻target interactions were created for all of the active compounds and compared with the drug molecules using the docking methodology.
650    _2
$a acetylcholinesterasa $x metabolismus $7 D000110
650    _2
$a zvířata $7 D000818
650    _2
$a benzen $x chemická syntéza $x chemie $x farmakologie $7 D001554
650    _2
$a butyrylcholinesterasa $x metabolismus $7 D002091
650    _2
$a karbamáty $x chemická syntéza $x chemie $x farmakologie $7 D002219
650    _2
$a cholinesterasové inhibitory $x chemická syntéza $x chemie $x farmakologie $7 D002800
650    _2
$a racionální návrh léčiv $7 D015195
650    _2
$a Electrophorus $7 D004593
650    _2
$a koně $7 D006736
650    _2
$a inhibiční koncentrace 50 $7 D020128
650    _2
$a ligandy $7 D008024
650    _2
$a simulace molekulového dockingu $7 D062105
650    _2
$a analýza hlavních komponent $7 D025341
650    _2
$a pravděpodobnost $7 D011336
650    _2
$a vztahy mezi strukturou a aktivitou $7 D013329
655    _2
$a časopisecké články $7 D016428
700    1_
$a Kozik, Violetta $u Institute of Chemistry, University of Silesia, Szkolna 9, 40 007 Katowice, Poland. violetta.kozik@us.edu.pl.
700    1_
$a Kozakiewicz, Dariusz $u Institute of Chemistry, University of Silesia, Szkolna 9, 40 007 Katowice, Poland. dkozakiewicz@us.edu.pl.
700    1_
$a Gajcy, Kamila $u Institute of Chemistry, University of Silesia, Szkolna 9, 40 007 Katowice, Poland. kamila.gajcy@us.edu.pl.
700    1_
$a Strub, Daniel Jan $u Department of Bioorganic Chemistry, Faculty of Chemistry, Wrocław University of Science and Technology, Wyb. Wyspiańskiego 27, 50-370 Wrocław, Poland. daniel.strub@pwr.edu.pl.
700    1_
$a Swietlicka, Aleksandra $u Institute of Chemistry, University of Silesia, Szkolna 9, 40 007 Katowice, Poland. aswietlicka@us.edu.pl.
700    1_
$a Stepankova, Sarka $u Department of Biological and Biochemical Sciences, Faculty of Chemical Technology, University of Pardubice, Studentska 573, 532 10 Pardubice, Czech Republic. sarka.stepankova@upce.cz.
700    1_
$a Imramovsky, Ales $u Institute of Organic Chemistry and Technology, Faculty of Chemical Technology, University of Pardubice, Studentska 573, 532 10 Pardubice, Czech Republic. ales.imramovsky@upce.cz.
700    1_
$a Polanski, Jaroslaw $u Institute of Chemistry, University of Silesia, Szkolna 9, 40 007 Katowice, Poland. jaroslaw.polanski@us.edu.pl.
700    1_
$a Smolinski, Adam $u Department of Energy Saving and Air Protection, Central Mining Institute, Plac Gwarkow 1, 40 166 Katowice, Poland. smolin@gig.katowice.pl.
700    1_
$a Jampilek, Josef $u Division of Biologically Active Complexes and Molecular Magnets, Regional Centre of Advanced Technologies and Materials, Faculty of Science, Palacky University, Slechtitelu 27, 78371 Olomouc, Czech Republic. josef.jampilek@gmail.com. Institute of Neuroimmunology, Slovak Academy of Sciences, Dubravska cesta 9, 84510, Bratislava, Slovakia. josef.jampilek@gmail.com.
773    0_
$w MED00176142 $t International journal of molecular sciences $x 1422-0067 $g Roč. 20, č. 7 (2019)
856    41
$u https://pubmed.ncbi.nlm.nih.gov/30934674 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20191007 $b ABA008
991    __
$a 20191008105542 $b ABA008
999    __
$a ok $b bmc $g 1451333 $s 1073223
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2019 $b 20 $c 7 $e 20190327 $i 1422-0067 $m International journal of molecular sciences $n Int J Mol Sci $x MED00176142
GRA    __
$a LO1305 $p Ministry of Education of the Czech Republic
GRA    __
$a APVV-17-0373 and APVV-14-0547 $p Slovak Research and Development Agency
LZP    __
$a Pubmed-20191007

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...